From October 1, 2022 to December 31, 2022, the company has repurchased 105,500 shares, representing 0.2% for SEK 0.65 million. With this, the company has completed the repurchase of 129,500 shares, representing 0.25% for SEK 0.83 million under the buyback announced on July 25, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.5 SEK | +2.44% | +14.13% | +13.64% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.64% | 51.49M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- INIT Stock
- News Initiator Pharma A/S
- Tranche Update on Initiator Pharma A/S (OM: INIT)'s Equity Buyback Plan announced on July 25, 2022.